CP1 Therapeutics Flashcards
Leading Cause of heart failure
Ischemic heart disease
Gold standard for CHF diagnosis
Echocardiogram showing <45% ejection fraction
Goals of treatment for CHF (6)
Identify/Treat Causes Reduce Cardiac Workload Increase Cardiac Output Counteract neurohormonal maladaptation Relieve symptoms Increase quality of life
Thromboembolism prophylaxis for Atrial Fibrillation
High-Med risk = Warfarin
Low risk = Aspirin
Pharmacological action of ACE-inhibitors
Inhibit RAAS by preventing conversion of angiotensin 1 to angiotensin 2
Examples of ACE inhibitors
enlapril, lisinopril, ramipril
Therapeutic effects of RAAS inhibition
Reduce arterial/venous vasoconstriction (reduce preload/afterload)
Reduce salt/water retention (reduce circulating volume)
Inhibit neurohormonal adaptation/cardiac remodelling
How should you implement an ACE-inhibitor regime
low dose then titrate upwards (may go past licensed max dose)
What should be monitored during ACE-i therapy
Urea/creatinine (renal function)
K+ (before and during treatment - hyperkalaemia)
Blood pressure
ACE-i Contraindications
NSAIDS
Severe renal imparment
Hypotension (<100mmHg)
Complications of ACE-i therapy
Hyperkalemia
Severe first dose hypotension (especially during concurrent diuretic therapy - should withhold in first few days of ACE-i introduction)
deterioration in renal health
Dry cough
Examples of AT1 receptor antagonists
Losartan, Candesartan, Valsartan
Pharmacology of AT1 receptor antagonists
Oppose actions of angiotensin at the AT1 receptor
Advantage of AT1 receptor antagonists
No cough whilst being equally as effective as ACE-is
Benefits of diuretics in heart failure
reduce circulating volume (reduce preload and afterload), cause venodialtion (reduce preload)
Complication of Diuretics
Hypokalaemia
Examples of Beta-blockers
Metoprolol, Bisoprolol, Carvedilol, Nebivolol
Benefits of using beta-blockers in CHF
reduce sympathetic stimulation of heart, oppose neurohormonal adaptation, anti-arrhythmic
What kind of failure are Beta blockers most effective at treating
ischemic heart failure
How should you implement a Beta-blocker regime for CHF
start low dose and titrate up
What should you counsel a patient for when starting beta-blockers
Symptoms may get worse initially
Contraindications of Beta-blockers
Asthma, symptomatic bradycardia, severe heart failure
What is the mechanism of Spironolactone
Aldosterone receptor antagonist
What is the role of Spironolactone in CHF
Reverses left ventricular hypertrophy at sub-diuretic doses - reducing mortality by 35%